These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Risk assessment of antibiotic residues of beta-lactams and macrolides in food products with regard to their immuno-allergic potential. Dewdney JM; Maes L; Raynaud JP; Blanc F; Scheid JP; Jackson T; Lens S; Verschueren C Food Chem Toxicol; 1991 Jul; 29(7):477-83. PubMed ID: 1894215 [TBL] [Abstract][Full Text] [Related]
26. Comparison of hypersensitivity reactions of intravenous iron: iron isomaltoside-1000 (Monofer Mulder MB; van den Hoek HL; Birnie E; van Tilburg AJP; Westerman EM Br J Clin Pharmacol; 2019 Feb; 85(2):385-392. PubMed ID: 30393904 [TBL] [Abstract][Full Text] [Related]
27. Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancer. Ohta H; Hayashi T; Murai S; Shiouchi H; Ando Y; Kumazawa S; Ito K; Ikeda Y; Matsuoka H; Maeda K; Kawada K; Yasuda K; Yamada S Cancer Chemother Pharmacol; 2017 May; 79(5):1021-1029. PubMed ID: 28391355 [TBL] [Abstract][Full Text] [Related]
28. Cyclo-oxygenase selectivity and chemical groups of nonsteroidal anti-inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBase. Bakhriansyah M; Meyboom RHB; Souverein PC; de Boer A; Klungel OH Fundam Clin Pharmacol; 2019 Oct; 33(5):589-600. PubMed ID: 30860620 [TBL] [Abstract][Full Text] [Related]
29. Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis. Yun H; Xie F; Beyl RN; Chen L; Lewis JD; Saag KG; Curtis JR Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1526-1534. PubMed ID: 27813327 [TBL] [Abstract][Full Text] [Related]
30. Evaluation and management of hypersensitivity to proton pump inhibitors. Bose S; Guyer A; Long A; Banerji A Ann Allergy Asthma Immunol; 2013 Dec; 111(6):452-7. PubMed ID: 24267357 [TBL] [Abstract][Full Text] [Related]
31. Hypersensitivity Reactions to Multiple Iodinated Contrast Media. Doña I; Bogas G; Salas M; Testera A; Moreno E; Laguna JJ; Torres MJ Front Pharmacol; 2020; 11():575437. PubMed ID: 33071787 [TBL] [Abstract][Full Text] [Related]
32. Incidence of and risk factors associated with nedaplatin-related hypersensitivity reactions. Kawarada Y; Miyazaki M; Itoh A; Araki R; Iwamizu H; Kataoka T; Kumakura Y; Ota A; Nagai T; Yamada K Int J Clin Oncol; 2017 Jun; 22(3):593-599. PubMed ID: 28124284 [TBL] [Abstract][Full Text] [Related]
33. Management of Hypersensitivity Reactions to Nondextran Iron Products: New Insights Into Predisposing Risk Factors. Steveling-Klein EH; Mateluna CM; Meienberg A; Hartmann K; Bircher A; Scherer Hofmeier K J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2406-2414.e2. PubMed ID: 33486145 [TBL] [Abstract][Full Text] [Related]
34. Reactions to cytostatic agents in children. Cernadas JR Curr Opin Allergy Clin Immunol; 2017 Aug; 17(4):255-261. PubMed ID: 28622171 [TBL] [Abstract][Full Text] [Related]
35. An update on adverse drug reactions related to β-lactam antibiotics. Vardakas KZ; Kalimeris GD; Triarides NA; Falagas ME Expert Opin Drug Saf; 2018 May; 17(5):499-508. PubMed ID: 29633867 [TBL] [Abstract][Full Text] [Related]
36. Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions. Bager P; Hvas CL; Dahlerup JF Br J Clin Pharmacol; 2017 May; 83(5):1118-1125. PubMed ID: 27859495 [TBL] [Abstract][Full Text] [Related]
37. Management of hypersensitivity reactions to Carboplatin and Paclitaxel in an outpatient oncology infusion center: a 5-year review. Banerji A; Lax T; Guyer A; Hurwitz S; Camargo CA; Long AA J Allergy Clin Immunol Pract; 2014; 2(4):428-33. PubMed ID: 25017531 [TBL] [Abstract][Full Text] [Related]
38. Utility of Risk Stratification for Paclitaxel Hypersensitivity Reactions. Otani IM; Lax T; Long AA; Slawski BR; Camargo CA; Banerji A J Allergy Clin Immunol Pract; 2018; 6(4):1266-1273.e2. PubMed ID: 28986119 [TBL] [Abstract][Full Text] [Related]
39. Do Steroids Matter? A Retrospective Review of Premedication for Taxane Chemotherapy and Hypersensitivity Reactions. Lansinger OM; Biedermann S; He Z; Colevas AD J Clin Oncol; 2021 Nov; 39(32):3583-3590. PubMed ID: 34357780 [TBL] [Abstract][Full Text] [Related]